位置:首页 > 蛋白库 > GRIA3_MOUSE
GRIA3_MOUSE
ID   GRIA3_MOUSE             Reviewed;         888 AA.
AC   Q9Z2W9; A2VDF4; Q5DTJ0;
DT   11-OCT-2005, integrated into UniProtKB/Swiss-Prot.
DT   27-JUL-2011, sequence version 2.
DT   03-AUG-2022, entry version 168.
DE   RecName: Full=Glutamate receptor 3;
DE            Short=GluR-3;
DE   AltName: Full=AMPA-selective glutamate receptor 3;
DE   AltName: Full=GluR-C;
DE   AltName: Full=GluR-K3;
DE   AltName: Full=Glutamate receptor ionotropic, AMPA 3;
DE            Short=GluA3;
DE   Flags: Precursor;
GN   Name=Gria3; Synonyms=Glur3, Kiaa4184;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=C57BL/6J;
RA   Sakimura K., Yamazaki M.;
RT   "Mouse glutamate receptor channel alpha3 subunit.";
RL   Submitted (JAN-1999) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=ddY; TISSUE=Spinal cord;
RA   Doi Y., Nishizawa M., Minami T., Ito S.;
RT   "Expression of AMPA-selective glutamate receptors in mouse spinal cord.";
RL   Submitted (JAN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=ILS, and ISS;
RX   PubMed=11471062; DOI=10.1007/s00335-001-1001-x;
RA   Ehringer M.A., Thompson J., Conroy O., Xu Y., Yang F., Canniff J.,
RA   Beeson M., Gordon L., Bennett B., Johnson T.E., Sikela J.M.;
RT   "High-throughput sequence identification of gene coding variants within
RT   alcohol-related QTLs.";
RL   Mamm. Genome 12:657-663(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RA   Okazaki N., Kikuno R.F., Ohara R., Inamoto S., Nagase T., Ohara O.,
RA   Koga H.;
RT   "Prediction of the coding sequences of mouse homologues of KIAA gene. The
RT   complete nucleotide sequences of mouse KIAA-homologous cDNAs identified by
RT   screening of terminal sequences of cDNA clones randomly sampled from size-
RT   fractionated libraries.";
RL   Submitted (FEB-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PALMITOYLATION AT CYS-841.
RX   PubMed=16129400; DOI=10.1016/j.neuron.2005.06.035;
RA   Hayashi T., Rumbaugh G., Huganir R.L.;
RT   "Differential regulation of AMPA receptor subunit trafficking by
RT   palmitoylation of two distinct sites.";
RL   Neuron 47:709-723(2005).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-871 AND TYR-881, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=18034455; DOI=10.1021/pr0701254;
RA   Ballif B.A., Carey G.R., Sunyaev S.R., Gygi S.P.;
RT   "Large-scale identification and evolution indexing of tyrosine
RT   phosphorylation sites from murine brain.";
RL   J. Proteome Res. 7:311-318(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 658-799 IN COMPLEX WITH
RP   GLUTAMATE, SUBUNIT, AND DISULFIDE BOND.
RX   PubMed=20163115; DOI=10.1021/jm901905j;
RA   Ahmed A.H., Oswald R.E.;
RT   "Piracetam defines a new binding site for allosteric modulators of alpha-
RT   amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptors.";
RL   J. Med. Chem. 53:2197-2203(2010).
CC   -!- FUNCTION: Receptor for glutamate that functions as ligand-gated ion
CC       channel in the central nervous system and plays an important role in
CC       excitatory synaptic transmission. L-glutamate acts as an excitatory
CC       neurotransmitter at many synapses in the central nervous system.
CC       Binding of the excitatory neurotransmitter L-glutamate induces a
CC       conformation change, leading to the opening of the cation channel, and
CC       thereby converts the chemical signal to an electrical impulse. The
CC       receptor then desensitizes rapidly and enters a transient inactive
CC       state, characterized by the presence of bound agonist. In the presence
CC       of CACNG4 or CACNG7 or CACNG8, shows resensitization which is
CC       characterized by a delayed accumulation of current flux upon continued
CC       application of glutamate (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Homotetramer or heterotetramer of pore-forming glutamate
CC       receptor subunits. Tetramers may be formed by the dimerization of
CC       dimers. Interacts with PRKCABP, GRIP1 and GRIP2 (By similarity). Found
CC       in a complex with GRIA1, GRIA2, GRIA4, CNIH2, CNIH3, CACNG2, CACNG3,
CC       CACNG4, CACNG5, CACNG7 and CACNG8. Interacts with CACNG5 (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Multi-pass membrane
CC       protein {ECO:0000250}. Postsynaptic cell membrane {ECO:0000250}; Multi-
CC       pass membrane protein {ECO:0000250}. Note=Interaction with CNIH2 and
CC       CNIH3 promotes cell surface expression. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=Flip;
CC         IsoId=Q9Z2W9-1; Sequence=Displayed;
CC       Name=Flop;
CC         IsoId=Q9Z2W9-2; Sequence=Not described;
CC   -!- DOMAIN: The M4 transmembrane segment mediates tetramerization and is
CC       required for cell surface expression. {ECO:0000250}.
CC   -!- PTM: Palmitoylated. Depalmitoylated upon glutamate stimulation. Cys-615
CC       palmitoylation leads to Golgi retention and decreased cell surface
CC       expression. In contrast, Cys-841 palmitoylation does not affect cell
CC       surface expression but regulates stimulation-dependent endocytosis (By
CC       similarity). {ECO:0000250}.
CC   -!- MISCELLANEOUS: The postsynaptic actions of Glu are mediated by a
CC       variety of receptors that are named according to their selective
CC       agonists. This receptor binds AMPA (quisqualate) > glutamate > kainate.
CC   -!- SIMILARITY: Belongs to the glutamate-gated ion channel (TC 1.A.10.1)
CC       family. GRIA3 subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAD90527.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB022342; BAA37124.1; -; mRNA.
DR   EMBL; AB079072; BAE06153.1; -; mRNA.
DR   EMBL; AF483494; AAL90768.1; -; mRNA.
DR   EMBL; AF483495; AAL90769.1; -; mRNA.
DR   EMBL; AK220530; BAD90527.1; ALT_INIT; mRNA.
DR   EMBL; CH466570; EDL29035.1; -; Genomic_DNA.
DR   EMBL; AL672232; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL672290; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC129855; AAI29856.1; -; mRNA.
DR   CCDS; CCDS30097.1; -. [Q9Z2W9-1]
DR   RefSeq; NP_001268858.1; NM_001281929.1. [Q9Z2W9-1]
DR   RefSeq; NP_058582.3; NM_016886.4. [Q9Z2W9-1]
DR   RefSeq; XP_006541583.1; XM_006541520.3.
DR   RefSeq; XP_017174034.1; XM_017318545.1. [Q9Z2W9-1]
DR   PDB; 3LSW; X-ray; 1.75 A; A=658-799.
DR   PDB; 3LSX; X-ray; 2.01 A; A=658-799.
DR   PDBsum; 3LSW; -.
DR   PDBsum; 3LSX; -.
DR   AlphaFoldDB; Q9Z2W9; -.
DR   SMR; Q9Z2W9; -.
DR   BioGRID; 207340; 10.
DR   IntAct; Q9Z2W9; 6.
DR   MINT; Q9Z2W9; -.
DR   STRING; 10090.ENSMUSP00000075687; -.
DR   ChEMBL; CHEMBL2096617; -.
DR   GlyConnect; 2343; 7 N-Linked glycans (2 sites).
DR   GlyGen; Q9Z2W9; 5 sites, 7 N-linked glycans (2 sites).
DR   iPTMnet; Q9Z2W9; -.
DR   PhosphoSitePlus; Q9Z2W9; -.
DR   SwissPalm; Q9Z2W9; -.
DR   MaxQB; Q9Z2W9; -.
DR   PaxDb; Q9Z2W9; -.
DR   PeptideAtlas; Q9Z2W9; -.
DR   PRIDE; Q9Z2W9; -.
DR   ProteomicsDB; 271162; -. [Q9Z2W9-1]
DR   Antibodypedia; 29962; 346 antibodies from 30 providers.
DR   DNASU; 53623; -.
DR   Ensembl; ENSMUST00000076349; ENSMUSP00000075687; ENSMUSG00000001986. [Q9Z2W9-1]
DR   GeneID; 53623; -.
DR   KEGG; mmu:53623; -.
DR   UCSC; uc009tal.3; mouse. [Q9Z2W9-1]
DR   CTD; 2892; -.
DR   MGI; MGI:95810; Gria3.
DR   VEuPathDB; HostDB:ENSMUSG00000001986; -.
DR   eggNOG; KOG1054; Eukaryota.
DR   GeneTree; ENSGT00940000156123; -.
DR   InParanoid; Q9Z2W9; -.
DR   TreeFam; TF315232; -.
DR   Reactome; R-MMU-399710; Activation of AMPA receptors.
DR   Reactome; R-MMU-416993; Trafficking of GluR2-containing AMPA receptors.
DR   Reactome; R-MMU-438066; Unblocking of NMDA receptors, glutamate binding and activation.
DR   Reactome; R-MMU-8849932; Synaptic adhesion-like molecules.
DR   BioGRID-ORCS; 53623; 2 hits in 74 CRISPR screens.
DR   ChiTaRS; Gria3; mouse.
DR   EvolutionaryTrace; Q9Z2W9; -.
DR   PRO; PR:Q9Z2W9; -.
DR   Proteomes; UP000000589; Chromosome X.
DR   RNAct; Q9Z2W9; protein.
DR   Bgee; ENSMUSG00000001986; Expressed in subiculum and 196 other tissues.
DR   ExpressionAtlas; Q9Z2W9; baseline and differential.
DR   Genevisible; Q9Z2W9; MM.
DR   GO; GO:0032281; C:AMPA glutamate receptor complex; IDA:MGI.
DR   GO; GO:0070161; C:anchoring junction; IEA:UniProtKB-KW.
DR   GO; GO:0032279; C:asymmetric synapse; ISO:MGI.
DR   GO; GO:0030425; C:dendrite; ISO:MGI.
DR   GO; GO:0043198; C:dendritic shaft; ISO:MGI.
DR   GO; GO:0043197; C:dendritic spine; ISO:MGI.
DR   GO; GO:0098978; C:glutamatergic synapse; ISO:MGI.
DR   GO; GO:0099061; C:integral component of postsynaptic density membrane; ISO:MGI.
DR   GO; GO:0099055; C:integral component of postsynaptic membrane; ISO:MGI.
DR   GO; GO:0099056; C:integral component of presynaptic membrane; ISO:MGI.
DR   GO; GO:0016020; C:membrane; IDA:MGI.
DR   GO; GO:0043025; C:neuronal cell body; ISO:MGI.
DR   GO; GO:0098688; C:parallel fiber to Purkinje cell synapse; IDA:SynGO.
DR   GO; GO:0043204; C:perikaryon; ISO:MGI.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0014069; C:postsynaptic density; ISO:MGI.
DR   GO; GO:0045211; C:postsynaptic membrane; IDA:MGI.
DR   GO; GO:0032991; C:protein-containing complex; ISO:MGI.
DR   GO; GO:0043083; C:synaptic cleft; ISO:MGI.
DR   GO; GO:0043195; C:terminal bouton; ISO:MGI.
DR   GO; GO:0004971; F:AMPA glutamate receptor activity; ISS:UniProtKB.
DR   GO; GO:0001540; F:amyloid-beta binding; ISO:MGI.
DR   GO; GO:0004970; F:ionotropic glutamate receptor activity; ISO:MGI.
DR   GO; GO:0015276; F:ligand-gated ion channel activity; IBA:GO_Central.
DR   GO; GO:0030165; F:PDZ domain binding; ISO:MGI.
DR   GO; GO:0038023; F:signaling receptor activity; IBA:GO_Central.
DR   GO; GO:1904315; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential; IDA:SynGO.
DR   GO; GO:0001919; P:regulation of receptor recycling; ISO:MGI.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR019594; Glu/Gly-bd.
DR   InterPro; IPR001508; Iono_rcpt_met.
DR   InterPro; IPR001320; Iontro_rcpt.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF00060; Lig_chan; 1.
DR   Pfam; PF10613; Lig_chan-Glu_bd; 1.
DR   PRINTS; PR00177; NMDARECEPTOR.
DR   SMART; SM00918; Lig_chan-Glu_bd; 1.
DR   SMART; SM00079; PBPe; 1.
DR   SUPFAM; SSF53822; SSF53822; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Disulfide bond;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Lipoprotein; Membrane; Palmitate; Phosphoprotein;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; Signal; Synapse;
KW   Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL          1..22
FT                   /evidence="ECO:0000255"
FT   CHAIN           23..888
FT                   /note="Glutamate receptor 3"
FT                   /id="PRO_0000042230"
FT   TOPO_DOM        23..546
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        547..567
FT                   /note="Helical"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        568..596
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   INTRAMEM        597..612
FT                   /note="Helical; Pore-forming"
FT                   /evidence="ECO:0000250"
FT   INTRAMEM        613..615
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        616..621
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        622..642
FT                   /note="Helical"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        643..817
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        818..838
FT                   /note="Helical; Name=M4"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        839..888
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   BINDING         474
FT                   /ligand="L-glutamate"
FT                   /ligand_id="ChEBI:CHEBI:29985"
FT                   /evidence="ECO:0000269|PubMed:20163115"
FT   BINDING         502..504
FT                   /ligand="L-glutamate"
FT                   /ligand_id="ChEBI:CHEBI:29985"
FT   BINDING         509
FT                   /ligand="L-glutamate"
FT                   /ligand_id="ChEBI:CHEBI:29985"
FT                   /evidence="ECO:0000269|PubMed:20163115"
FT   BINDING         680..681
FT                   /ligand="L-glutamate"
FT                   /ligand_id="ChEBI:CHEBI:29985"
FT   BINDING         731
FT                   /ligand="L-glutamate"
FT                   /ligand_id="ChEBI:CHEBI:29985"
FT                   /evidence="ECO:0000269|PubMed:20163115"
FT   MOD_RES         871
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:18034455"
FT   MOD_RES         881
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:18034455"
FT   LIPID           615
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250"
FT   LIPID           841
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000269|PubMed:16129400"
FT   CARBOHYD        57
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        260
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        374
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        409
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        416
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        85..334
FT                   /evidence="ECO:0000250"
FT   DISULFID        744..799
FT                   /evidence="ECO:0000269|PubMed:20163115"
FT   CONFLICT        300
FT                   /note="T -> I (in Ref. 4; BAD90527)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        769
FT                   /note="R -> G (in Ref. 1; BAA37124/BAE06153, 3; AAL90768/
FT                   AAL90769 and 4; BAD90527)"
FT                   /evidence="ECO:0000305"
FT   STRAND          418..423
FT                   /evidence="ECO:0007829|PDB:3LSW"
FT   TURN            427..429
FT                   /evidence="ECO:0007829|PDB:3LSW"
FT   STRAND          430..432
FT                   /evidence="ECO:0007829|PDB:3LSW"
FT   HELIX           436..438
FT                   /evidence="ECO:0007829|PDB:3LSW"
FT   HELIX           441..444
FT                   /evidence="ECO:0007829|PDB:3LSW"
FT   STRAND          445..447
FT                   /evidence="ECO:0007829|PDB:3LSW"
FT   HELIX           448..460
FT                   /evidence="ECO:0007829|PDB:3LSW"
FT   STRAND          463..468
FT                   /evidence="ECO:0007829|PDB:3LSW"
FT   TURN            479..481
FT                   /evidence="ECO:0007829|PDB:3LSW"
FT   HELIX           486..492
FT                   /evidence="ECO:0007829|PDB:3LSW"
FT   STRAND          497..499
FT                   /evidence="ECO:0007829|PDB:3LSW"
FT   HELIX           507..510
FT                   /evidence="ECO:0007829|PDB:3LSW"
FT   STRAND          513..515
FT                   /evidence="ECO:0007829|PDB:3LSW"
FT   STRAND          519..522
FT                   /evidence="ECO:0007829|PDB:3LSW"
FT   STRAND          524..529
FT                   /evidence="ECO:0007829|PDB:3LSW"
FT   HELIX           662..666
FT                   /evidence="ECO:0007829|PDB:3LSW"
FT   STRAND          669..676
FT                   /evidence="ECO:0007829|PDB:3LSW"
FT   HELIX           680..687
FT                   /evidence="ECO:0007829|PDB:3LSW"
FT   HELIX           691..702
FT                   /evidence="ECO:0007829|PDB:3LSW"
FT   STRAND          708..711
FT                   /evidence="ECO:0007829|PDB:3LSW"
FT   HELIX           712..721
FT                   /evidence="ECO:0007829|PDB:3LSW"
FT   TURN            722..724
FT                   /evidence="ECO:0007829|PDB:3LSW"
FT   STRAND          725..731
FT                   /evidence="ECO:0007829|PDB:3LSW"
FT   HELIX           732..739
FT                   /evidence="ECO:0007829|PDB:3LSW"
FT   STRAND          746..750
FT                   /evidence="ECO:0007829|PDB:3LSW"
FT   STRAND          756..758
FT                   /evidence="ECO:0007829|PDB:3LSW"
FT   STRAND          761..763
FT                   /evidence="ECO:0007829|PDB:3LSW"
FT   HELIX           770..781
FT                   /evidence="ECO:0007829|PDB:3LSW"
FT   HELIX           784..793
FT                   /evidence="ECO:0007829|PDB:3LSW"
FT   TURN            794..796
FT                   /evidence="ECO:0007829|PDB:3LSW"
SQ   SEQUENCE   888 AA;  100527 MW;  9F68C5D80E81DC02 CRC64;
     MGQSVLRAVF FLVLGLLGHS HGGFPNTISI GGLFMRNTVQ EHSAFRFAVQ LYNTNQNTTE
     KPFHLNYHVD HLDSSNSFSV TNAFCSQFSR GVYAIFGFYD QMSMNTLTSF CGALHTSFVT
     PSFPTDADVQ FVIQMRPALK GAILSLLGYY KWEKFVYLYD TERGFSILQA IMEAAVQNNW
     QVTARSVGNI KDIQEFRRII EEMDRRQEKR YLIDCEVERI NTILEQVVIL GKHSRGYHYM
     LANLGFTDIV LERVMHGGAN ITGFQIVNNE NPMVQQFIQR WVRLDEREFP EAKNAPLKYT
     SALTHDAILV IAEAFRYLRR QRVDVSRRGS AGDCLANPAV PWSQGIDIER ALKMVQVQGM
     TGNIQFDTYG RRTNYTIDVY EMKVSGSRKA GYWNEYERFV PFSDQQISND SSSSENRTIV
     VTTILESPYV MYKKNHEQLE GNERYEGYCV DLAYEIAKHV RIKYKLSIVG DGKYGARDPE
     TKIWNGMVGE LVYGRADIAV APLTITLVRE EVIDFSKPFM SLGISIMIKK PQKSKPGVFS
     FLDPLAYEIW MCIVFAYIGV SVVLFLVSRF SPYEWHLEDN NEEPRDPQSP PDPPNEFGIF
     NSLWFSLGAF MQQGCDISPR SLSGRIVGGV WWFFTLIIIS SYTANLAAFL TVERMVSPIE
     SAEDLAKQTE IAYGTLDSGS TKEFFRRSKI AVYEKMWSYM KSAEPSVFTK TTADGVARVR
     KSKGKFAFLL ESTMNEYIEQ RKPCDTMKVG GNLDSKGYGV ATPKGSALRT PVNLAVLKLS
     EQGILDKLKN KWWYDKGECG AKDSGSKDKT SALSLSNVAG VFYILVGGLG LAMMVALIEF
     CYKSRAESKR MKLTKNTQNF KPAPATNTQN YATYREGYNV YGTESVKI
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024